vs
Side-by-side financial comparison of FOX FACTORY HOLDING CORP (FOXF) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
FOX FACTORY HOLDING CORP is the larger business by last-quarter revenue ($376.4M vs $339.0M, roughly 1.1× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs -0.2%, a 13.4% gap on every dollar of revenue. On growth, FOX FACTORY HOLDING CORP posted the faster year-over-year revenue change (4.8% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $-2.5M). Over the past eight quarters, FOX FACTORY HOLDING CORP's revenue compounded faster (6.4% CAGR vs 0.4%).
Fox Factory Holding Corp. is an American company best known for their Fox Racing Shox brand of off-road racing suspension components.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FOXF vs HAE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $376.4M | $339.0M |
| Net Profit | $-634.0K | $44.7M |
| Gross Margin | 30.4% | 59.7% |
| Operating Margin | 4.0% | 19.9% |
| Net Margin | -0.2% | 13.2% |
| Revenue YoY | 4.8% | -2.7% |
| Net Profit YoY | -113.3% | 19.3% |
| EPS (diluted) | $-0.02 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $376.4M | $339.0M | ||
| Q3 25 | $374.9M | $327.3M | ||
| Q2 25 | $355.0M | $321.4M | ||
| Q1 25 | $352.8M | $330.6M | ||
| Q4 24 | — | $348.5M | ||
| Q3 24 | $359.1M | $345.5M | ||
| Q2 24 | $348.5M | $336.2M | ||
| Q1 24 | $333.5M | — |
| Q4 25 | $-634.0K | $44.7M | ||
| Q3 25 | $2.7M | $38.7M | ||
| Q2 25 | $-259.7M | $34.0M | ||
| Q1 25 | $-141.0K | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $4.8M | $33.8M | ||
| Q2 24 | $5.4M | $38.4M | ||
| Q1 24 | $-3.5M | — |
| Q4 25 | 30.4% | 59.7% | ||
| Q3 25 | 31.2% | 59.5% | ||
| Q2 25 | 30.9% | 59.8% | ||
| Q1 25 | 28.9% | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | 29.9% | 54.2% | ||
| Q2 24 | 31.8% | 52.0% | ||
| Q1 24 | 30.9% | — |
| Q4 25 | 4.0% | 19.9% | ||
| Q3 25 | 4.9% | 17.9% | ||
| Q2 25 | -70.6% | 16.8% | ||
| Q1 25 | 3.2% | 21.6% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | 5.2% | 15.0% | ||
| Q2 24 | 5.3% | 11.8% | ||
| Q1 24 | 2.7% | — |
| Q4 25 | -0.2% | 13.2% | ||
| Q3 25 | 0.7% | 11.8% | ||
| Q2 25 | -73.1% | 10.6% | ||
| Q1 25 | -0.0% | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | 1.3% | 9.8% | ||
| Q2 24 | 1.6% | 11.4% | ||
| Q1 24 | -1.0% | — |
| Q4 25 | $-0.02 | $0.95 | ||
| Q3 25 | $0.07 | $0.81 | ||
| Q2 25 | $-6.23 | $0.70 | ||
| Q1 25 | $0.00 | $1.17 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | $0.11 | $0.66 | ||
| Q2 24 | $0.13 | $0.74 | ||
| Q1 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $363.4M |
| Total DebtLower is stronger | $536.7M | $1.2B |
| Stockholders' EquityBook value | $956.0M | $911.5M |
| Total Assets | $2.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.56× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | $71.7M | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M | ||
| Q1 24 | — | — |
| Q4 25 | $536.7M | $1.2B | ||
| Q3 25 | $541.8M | $1.2B | ||
| Q2 25 | $546.9M | $1.2B | ||
| Q1 25 | $552.1M | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | $558.4M | — | ||
| Q2 24 | $564.1M | — | ||
| Q1 24 | $370.4M | — |
| Q4 25 | $956.0M | $911.5M | ||
| Q3 25 | $958.7M | $849.2M | ||
| Q2 25 | $939.9M | $882.3M | ||
| Q1 25 | $1.2B | $820.8M | ||
| Q4 24 | — | $906.9M | ||
| Q3 24 | $1.2B | $878.9M | ||
| Q2 24 | $1.2B | $905.4M | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $2.0B | $2.5B | ||
| Q3 25 | $2.0B | $2.4B | ||
| Q2 25 | $1.9B | $2.5B | ||
| Q1 25 | $2.2B | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $2.3B | $2.5B | ||
| Q2 24 | $2.3B | $2.5B | ||
| Q1 24 | $2.2B | — |
| Q4 25 | 0.56× | 1.34× | ||
| Q3 25 | 0.57× | 1.44× | ||
| Q2 25 | 0.58× | 1.39× | ||
| Q1 25 | 0.46× | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.3M | $93.6M |
| Free Cash FlowOCF − Capex | $-2.5M | $87.2M |
| FCF MarginFCF / Revenue | -0.7% | 25.7% |
| Capex IntensityCapex / Revenue | 2.1% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $85.4M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3M | $93.6M | ||
| Q3 25 | $36.8M | $111.3M | ||
| Q2 25 | $680.0K | $17.4M | ||
| Q1 25 | $81.7M | $116.6M | ||
| Q4 24 | — | $43.8M | ||
| Q3 24 | $14.1M | $48.8M | ||
| Q2 24 | $26.7M | $-27.4M | ||
| Q1 24 | $9.4M | — |
| Q4 25 | $-2.5M | $87.2M | ||
| Q3 25 | $24.6M | $106.3M | ||
| Q2 25 | $-6.5M | $13.6M | ||
| Q1 25 | $69.8M | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | $3.2M | $39.4M | ||
| Q2 24 | $15.4M | $-33.1M | ||
| Q1 24 | $-555.0K | — |
| Q4 25 | -0.7% | 25.7% | ||
| Q3 25 | 6.6% | 32.5% | ||
| Q2 25 | -1.8% | 4.2% | ||
| Q1 25 | 19.8% | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 0.9% | 11.4% | ||
| Q2 24 | 4.4% | -9.8% | ||
| Q1 24 | -0.2% | — |
| Q4 25 | 2.1% | 1.9% | ||
| Q3 25 | 3.3% | 1.5% | ||
| Q2 25 | 2.0% | 1.2% | ||
| Q1 25 | 3.4% | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | 3.0% | 2.7% | ||
| Q2 24 | 3.2% | 1.7% | ||
| Q1 24 | 3.0% | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | 13.41× | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | 2.94× | 1.44× | ||
| Q2 24 | 4.94× | -0.71× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOXF
| Specialty Sports Group | $132.7M | 35% |
| Powered Vehicles Group | $125.9M | 33% |
| Aftermarket Applications Group | $117.8M | 31% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
